SE0004053D0 - N-type calcium channel antagonists for the treatment of pain - Google Patents

N-type calcium channel antagonists for the treatment of pain

Info

Publication number
SE0004053D0
SE0004053D0 SE0004053A SE0004053A SE0004053D0 SE 0004053 D0 SE0004053 D0 SE 0004053D0 SE 0004053 A SE0004053 A SE 0004053A SE 0004053 A SE0004053 A SE 0004053A SE 0004053 D0 SE0004053 D0 SE 0004053D0
Authority
SE
Sweden
Prior art keywords
treatment
pain
calcium channel
type calcium
channel antagonists
Prior art date
Application number
SE0004053A
Other languages
English (en)
Swedish (sv)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0004053A priority Critical patent/SE0004053D0/xx
Publication of SE0004053D0 publication Critical patent/SE0004053D0/xx
Priority to JP2002539345A priority patent/JP2004513125A/ja
Priority to AT01981239T priority patent/ATE323693T1/de
Priority to PCT/SE2001/002388 priority patent/WO2002036586A1/en
Priority to AU2002212894A priority patent/AU2002212894A1/en
Priority to EP01981239A priority patent/EP1339706B1/en
Priority to US10/415,785 priority patent/US6815447B2/en
Priority to ES01981239T priority patent/ES2261496T3/es
Priority to DE60118956T priority patent/DE60118956T2/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0004053A 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain SE0004053D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain
JP2002539345A JP2004513125A (ja) 2000-11-06 2001-10-31 疼痛治療のためのｎ−型カルシウムチャンネル拮抗薬
AT01981239T ATE323693T1 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
PCT/SE2001/002388 WO2002036586A1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
AU2002212894A AU2002212894A1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
EP01981239A EP1339706B1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
US10/415,785 US6815447B2 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
ES01981239T ES2261496T3 (es) 2000-11-06 2001-10-31 Antagonistas de los canales de calcio de tipo n para el tratamiento del dolor.
DE60118956T DE60118956T2 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
SE0004053D0 true SE0004053D0 (sv) 2000-11-06

Family

ID=20281713

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Country Status (9)

Country Link
US (1) US6815447B2 (ja)
EP (1) EP1339706B1 (ja)
JP (1) JP2004513125A (ja)
AT (1) ATE323693T1 (ja)
AU (1) AU2002212894A1 (ja)
DE (1) DE60118956T2 (ja)
ES (1) ES2261496T3 (ja)
SE (1) SE0004053D0 (ja)
WO (1) WO2002036586A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
DE60335635D1 (de) * 2002-05-22 2011-02-17 Amgen Inc Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen
TW200410945A (en) 2002-08-08 2004-07-01 Amgen Inc Vanilloid receptor ligands and their use in treatments"
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
CA2507100C (en) 2002-11-21 2012-10-09 Chiron Corporation 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
JP4691041B2 (ja) * 2003-11-20 2011-06-01 チルドレンズ ホスピタル メディカル センター Ｇｔｐアーゼ阻害剤および使用方法
US7301022B2 (en) 2005-02-15 2007-11-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
JP2008534630A (ja) * 2005-04-08 2008-08-28 ニューロメッド ファーマシューティカルズ リミテッド 疼痛の軽減のためのｎ型カルシウムチャネルブロッカーを含む組み合わせ治療の方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
EP2019676A2 (en) * 2006-05-11 2009-02-04 Neuromed Pharmaceuticals, Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
EP2118087B1 (en) 2007-02-06 2012-03-28 Novartis AG Pi 3-kinase inhibitors and methods of their use
AU2011223888B2 (en) 2010-03-04 2015-07-02 Merck Sharp & Dohme Llc Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
CA2789474A1 (en) * 2010-03-04 2011-09-09 Merck Sharp & Dohme Corp. Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
EP2542076B1 (en) * 2010-03-04 2021-01-13 Merck Sharp & Dohme Corp. Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
MX2013010306A (es) 2011-03-08 2013-12-09 Zalicus Pharmaceuticals Ltd Formulaciones de dispersion solida y metodos de uso de las mismas.
EP2771337B1 (en) 2011-09-27 2017-08-02 Novartis AG 3-(pyrimidin-4-yl)-oxazolidin-2-ones as inhibitors of mutant idh
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
CA2903979A1 (en) 2013-03-14 2014-09-18 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794043A (en) * 1955-06-03 1958-04-30 Ici Ltd New quinoline derivatives
RU2202344C2 (ru) * 1998-03-26 2003-04-20 Джапан Тобакко Инк. Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции

Also Published As

Publication number Publication date
DE60118956D1 (de) 2006-05-24
ATE323693T1 (de) 2006-05-15
US20040058945A1 (en) 2004-03-25
DE60118956T2 (de) 2007-03-15
WO2002036586A1 (en) 2002-05-10
EP1339706A1 (en) 2003-09-03
EP1339706B1 (en) 2006-04-19
ES2261496T3 (es) 2006-11-16
JP2004513125A (ja) 2004-04-30
AU2002212894A1 (en) 2002-05-15
US6815447B2 (en) 2004-11-09

Similar Documents

Publication Publication Date Title
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9504661D0 (sv) New compounds
PT1157037E (pt) Conjugados de gcsf
NO20026064D0 (no) Nye forbindelser
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
PT1411908E (pt) Tratamento de infeccoes da unha com no
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
ATE233274T1 (de) Oxyiminopregnancarbolactone
ATE484508T1 (de) Furylverbindungen
SE9802729D0 (sv) Novel Compounds
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
CY1108808T1 (el) Ενωσεις μοτιλιδης
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE0302139D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
MY133969A (en) Indoloquinazolinones
EA200001039A1 (ru) Кальцилитические соединения
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
SE0003476D0 (sv) Compounds
SE0203300D0 (sv) Novel Compounds
DE60137534D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
SE0004055D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE0302755D0 (sv) Novel compounds
CY1106903T1 (el) Φαρμακευτικος συνδυασμος για τη θεραπεια της σπαστικοτητας και/ή του πονου